| Issue Date | Title | Author(s) |
| 2017-11-21 | Targeting the master regulator mTOR: A new approach to prevent the neurological of consequences of parasitic infections? | Donnelly, S; Huston, WM; Johnson, M; Tiberti, N; Saunders, B; O'Brien, B; Burke, C; Labbate, M; Combes, V |
| 2014-01-01 | Production, Fate and Pathogenicity of Plasma Microparticles in Murine Cerebral Malaria | El-Assaad, F; Wheway, J; Hunt, NH; Grau, GER; Combes, V |
| 2011-10-01 | CNS hypoxia is more pronounced in murine cerebral than noncerebral malaria and is reversed by erythropoietin | Hempel, C; Combes, V; Hunt, NH; Kurtzhals, JAL; Grau, GER |
| 2013-12-17 | Cell-derived microparticles: New targets in the therapeutic management of disease | Roseblade, A; Luk, F; Rawling, T; Ung, A; Grau, GER; Bebawy, M |
| 1998-10-10 | Inducible nitric oxide synthase polymorphism and fatal cerebral malaria. | Burgner, D; Xu, W; Rockett, K; Gravenor, M; Charles, IG; Hill, AV; Kwiatkowski, D |
| 2016-12-05 | Exploring experimental cerebral malaria pathogenesis through the characterisation of host-derived plasma microparticle protein content | Tiberti, N; Latham, SL; Bush, S; Cohen, A; Opoka, RO; John, CC; Juillard, A; Grau, GE; Combes, V |
| 2011-11-02 | Quantitation of brain edema and localisation of aquaporin 4 expression in relation to susceptibility to experimental cerebral malaria | Ampawong, S; Combes, V; Hunt, NH; Radford, J; Chan-Ling, T; Pongponratn, E; Grau, GER |
| 2014-01-01 | Potential Efficacy of Citicoline as Adjunct Therapy in Treatment of Cerebral Malaria | El-Assaad, F; Combes, V; Raymond Grau, GE; Jamboua, R |
| 2011-02-01 | Coincident parasite and CD8 T cell sequestration is required for development of experimental cerebral malaria | McQuillan, JA; Mitchell, AJ; Ho, YF; Combes, V; Ball, HJ; Golenser, J; Grau, GE; Hunt, NH |
| 2018-05-11 | Differential plasma microvesicle and brain profiles of microRNA in experimental cerebral malaria | Cohen, A; Zinger, A; Tiberti, N; Grau, GER; Combes, V |
